Espa?ol
PDFs by language
Our 24/7 cancer helpline provides information and answers for people dealing with cancer. We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear.
Live Chat available weekdays, 7:00 am - 6:30 pm CT
Call us at 1-800-227-2345
Available any time of day or night
Our highly trained specialists are available 24/7 via phone and on weekdays can assist through online chat. We connect patients, caregivers, and family members with essential services and resources at every step of their cancer journey. Ask us how you can get involved and support the fight against cancer. Some of the topics we can assist with include:
For medical questions, we encourage you to review our information with your doctor.
Most eye cancers are melanomas (also known as ocular melanomas or intraocular melanomas).
Radiation therapy uses high-energy x-rays to kill cancer cells. It is the most common treatment for eye melanoma.
Radiation therapy can often save some vision in the eye, although sometimes vision might be lost if the radiation damages other parts of the eye. An advantage of radiation over surgery is that the eye structure is preserved, which can result in a better appearance after treatment.
Different types of radiation therapy can be used to treat eye cancers.
Brachytherapy (also called ocular brachytherapy or episcleral plaque therapy) is the most common radiation treatment for eye melanoma. Studies have shown that it is as effective as removing the eye with surgery (enucleation).
How brachytherapy works:
How it¡¯s done:
It may take 3 to 6 months to see the full effect of the radiation on the tumor.
Brachytherapy cures about 9 out of 10 small to medium-size tumors. It can preserve vision in some people, depending on what part of the eye the melanoma is in. The outlook for vision is not as good if the tumor is very close to the optic nerve near the back of the eye, which carries visual images from the eye to the brain.
Proton beam radiation therapy uses a machine to focus a beam of radiation on a tumor. It¡¯s different from standard external beam radiation therapy because it uses a beam of protons instead of x-rays. A proton beam delivers radiation to the tumor by releasing its energy at a specific distance, causing less damage to the healthy tissue it passes through.
For eye melanomas, proton beam radiation therapy might be a better option than brachytherapy if the tumor cannot be completely covered with a plaque because of its size, shape, or location. For example, it¡¯s used more often for larger tumors or tumors close to the optic nerve. But not all cancer centers have the specialized machines needed for this treatment.
Getting treatment is much like getting an x-ray, but the dose of radiation is much higher. The treatment is not painful. In most cases, the total dose of radiation is divided into daily fractions over several days.
These treatments are not used as often as brachytherapy or proton beam therapy as the initial treatment for eye melanomas. They are both used to deliver a large, precise radiation dose to the tumor area.
Different machines can be used to deliver radiation in one of two ways:
Traditional external beam radiation therapy using wider beams of x-rays (photons) may be used in some situations, such as:
The main concern with radiation therapy is damage to parts of the eye. This can lead to problems such as:
Sometimes, treatments might result in partial or complete loss of vision or other problems, which might not happen right away and may worsen with time. The risk depends on the size and location of the tumor.
When the radiation is focused only on the affected eye, it is not likely to affect vision in the other eye or to cause other side effects sometimes linked with radiation therapy, such as hair loss or nausea.
To learn more about how radiation is used to treat cancer, see Radiation Therapy.
To learn about some of the side effects listed here and how to manage them, see Managing Cancer-related Side Effects.
Developed by the ÁñÁ«ÊÓÆµ medical and editorial content team with medical review and contribution by the American Society of Clinical Oncology (ASCO).
Harbour JW, Shih HA. Initial management of uveal and conjunctival melanomas. UpToDate. 2025. Accessed at https://www.uptodate.com/contents/initial-management-of-uveal-and-conjunctival-melanomas on April 10, 2025.
Houghton O, Gordon K. Chapter 64: Ocular Tumors. In: Niederhuber JE, Armitage JO, Doroshow JH, Kastan MB, Tepper JE, eds. Abeloff¡¯s Clinical Oncology. 6th ed. Philadelphia, Pa. Elsevier: 2020.
National Cancer Institute. Intraocular (Uveal) Melanoma Treatment (PDQ?)¨CHealth Professional Version. 2024. Accessed at https://www.cancer.gov/types/eye/hp/intraocular-melanoma-treatment-pdq on April 10, 2025.
National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Melanoma: Uveal. V.1.2025. Accessed at https://www.nccn.org on April 10, 2025.
Last Revised: May 5, 2025
ÁñÁ«ÊÓÆµ medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.
Sign up to stay up-to-date with news, valuable information, and ways to get involved with the ÁñÁ«ÊÓÆµ.